Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, January 10, 2024

Smart clothing maker Nanowear collects FDA AI clearance for cuffless blood pressure monitoring

How long before your competent? doctor gets this prescribed for you?

Smart clothing maker Nanowear collects FDA AI clearance for cuffless blood pressure monitoring

The maker of a wearable garment for tracking heart rate, breathing and physical activity has obtained an FDA clearance for artificial intelligence-powered software that enables continuous monitoring of blood pressure without an inflatable cuff.

Fit snugly across a person’s chest, Nanowear’s SimpleSense wearable is built with cloth-based sensor technology to provide medical-grade remote vital sign tracking, including ECG data and heart sounds.

The new 510(k) green light—marking the company’s fourth—for the SimpleSense-BP program aims to support the at-home diagnosis of hypertension, as well as within healthcare facilities or clinical studies. Everyday settings can lead to more accurate readings than under the examination of a physician, where anxiety may raise blood pressure levels while calm, controlled breathing may lower them.

Nanowear SimpleSense
The sash-like SimpleSense undergarment is also being developed for tracking COPD and sleep apnea.   (Nanowear)

“This FDA clearance represents an exciting and differentiating moment for Nanowear,” co-founder and CEO Venk Varadan said in a statement. “Accelerated by the pandemic, the market has been eagerly searching for reliable, clinical-grade wearable, and data service solutions that find product market fit with the following three attributes: at-home, utilizing AI, and a proven team that executes.”

According to the company, SimpleSense-BP has been validated to log changes of more than 15 mmHg systolic and 10 mmHg diastolic blood pressures over a continuous recording period. 

Related

No comments:

Post a Comment